ADA: Once-Weekly Tirzepatide Leads to Weight Loss in Patients With Obesity, T2D
TUESDAY, June 27, 2023 (HealthDay News) — Once-weekly tirzepatide provides substantial and clinically meaningful reductions in body weight in adults with obesity and type 2 diabetes, according to a study published online June 26 in the The Lancet to …
Learn MoreWeight-Loss Surgery Can Keep Diabetes at Bay for Years: Study
TUESDAY, June 27, 2023 (HealthDay News) — Gastric bypass surgery is a potential long-term cure for type 2 diabetes, especially if the procedure is performed before the disease progresses, a new study argues.Among a large group of obese people with ty…
Learn MoreEn 2050, 1.3 mil millones de personas podrían tener diabetes en todo el mundo
VIERNES, 23 de junio de 2023 (HealthDay News) — La diabetes se está disparando, más de 500 millones de personas de todas las edades viven con la enfermedad hoy en día, y se proyecta que el número de casos alcance los 1.3 mil millones en todo el mundo…
Learn MoreADA: Glycemic Control Up With Weekly Icodec Versus Daily Insulin Glargine
MONDAY, June 26, 2023 (HealthDay News) — For adults with type 2 diabetes, glycemic control is significantly better with once-weekly icodec than once-daily insulin glargine U100, according to a study published online June 24 in the New England Journal…
Learn MoreNew Drugs Line Up to Challenge Ozempic, Wegovy for Weight Loss
MONDAY, June 26, 2023 (HealthDay News) — After drugmaker Novo Nordisk tweaked its diabetes drug Ozempic into Wegovy — a formulation expressly designed to help users shed pounds — sales of both drugs skyrocketed.Other pharmaceutical giants took notice…
Learn More1.3 Billion People Worldwide Could Have Diabetes by 2050
FRIDAY, June 23, 2023 (HealthDay News) — Diabetes is skyrocketing, with more than 500 million people of all ages living with the disease today and the number of cases worldwide projected to hit 1.3 billion in the next 30 years.”The rapid rate at whic…
Learn MoreLa FDA aprueba nuevos fármacos para tratar la diabetes tipo 2 en niños
MIÉRCOLES, 21 de junio de 2023 (HealthDay News) — El martes, la Administración de Alimentos y Medicamentos (FDA) de EE. UU. aprobó dos medicamentos que se han usado en adultos con diabetes tipo 2 durante años para su uso en niños de a partir de 10 añ…
Learn MoreFDA Approves New Drugs to Treat Type 2 Diabetes in Children
WEDNESDAY, June 21, 2023 (HealthDay News) — The U.S. Food and Drug Administration on Tuesday approved two drugs that have been used in adults with type 2 diabetes for years for use in children aged 10 years and older.The approvals of Jardiance (empag…
Learn MoreFDA Approves New Drugs to Treat Type 2 Diabetes in Kids
WEDNESDAY, June 21, 2023 (HealthDay News) — The U.S. Food and Drug Administration on Tuesday approved two drugs that have been used in adults with type 2 diabetes for years for use in children aged 10 and up. The approvals of Jardiance (empagliflozin…
Learn MoreAyunar a una hora más tarde de día podría ser clave para controlar el azúcar en la sangre, según un estudio
JUEVES, 15 de junio de 2023 (HealthDay News) — El ayuno intermitente está muy de moda, debido a la larga lista de beneficios asociados con este estilo de alimentación.Ahora, un nuevo estudio de tamaño reducido sugiere que un tipo de ayuno intermitent…
Learn More